Rankings
▼
Calendar
RGEN Q1 2019 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena
RGEN
Repligen Corporation
$7B
Q1 2019 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$61M
+35.3% YoY
Gross Profit
$34M
55.7% margin
Operating Income
$11M
18.4% margin
Net Income
$8M
13.3% margin
EPS (Diluted)
$0.17
QoQ Revenue Growth
+16.7%
Cash Flow
Operating Cash Flow
$10M
Free Cash Flow
$6M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$798M
Total Liabilities
$173M
Stockholders' Equity
$625M
Cash & Equivalents
$196M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$61M
$45M
+35.3%
Gross Profit
$34M
$25M
+34.3%
Operating Income
$11M
$6M
+86.9%
Net Income
$8M
$3M
+133.6%
Revenue Segments
Filtration Products
$29M
48%
Protein Products
$17M
27%
Chromatography Products
$14M
23%
Other products
$1M
2%
← FY 2019
All Quarters
Q2 2019 →